Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunologic Effects of CpG ODN Administration to HIV Uninfected and HIV Infected Patients

NCT00100633 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00100633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunologic Effects of CpG ODN Administration to HIV Uninfected and HIV Infected Patients
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2004
Completion date
October 31, 2007
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hiv infections